Skip to main content
Top
Published in: Abdominal Radiology 10/2016

01-10-2016 | Pictorial Essay

Stereotactic body radiation therapy of liver tumors: post-treatment appearances and evaluation of treatment response: a pictorial review

Authors: Mustafa M. Haddad, Kenneth W. Merrell, Christopher L. Hallemeier, Geoffrey B. Johnson, Taofic Mounajjed, Kenneth R. Olivier, Jeff L. Fidler, Sudhakar K. Venkatesh

Published in: Abdominal Radiology | Issue 10/2016

Login to get access

Abstract

Stereotactic body radiation therapy (SBRT) is a noninvasive treatment technique for selected patients with primary liver tumors and liver-confined oligometastatic disease. Recently, SBRT has emerged as an alternative treatment option in non-surgical candidates and in whom percutaneous treatment methods are not possible or contraindicated. The experience with SBRT continues to grow. There are currently no imaging guidelines for assessment of tumor response and follow-up schedule following SBRT. SBRT produces characteristic radiation-induced changes in the treated tumor and surrounding liver parenchyma. Knowledge of these changes is essential in the interpretation of follow-up imaging and assessment of treatment response. In this review, we will describe the CT, MRI, and PET imaging findings following SBRT of both the targeted liver tumor and surrounding hepatic parenchyma.
Literature
1.
go back to reference Kirkpatrick JP, Kelsey CR, Palta M, et al. (2014) Stereotactic body radiotherapy: a critical review for nonradiation oncologists. Cancer 120:942–954CrossRefPubMed Kirkpatrick JP, Kelsey CR, Palta M, et al. (2014) Stereotactic body radiotherapy: a critical review for nonradiation oncologists. Cancer 120:942–954CrossRefPubMed
2.
3.
go back to reference Price TR, Perkins SM, Sandrasegaran K, et al. (2012) Evaluation of response after stereotactic body radiotherapy for hepatocellular carcinoma. Cancer 118:3191–3198CrossRefPubMed Price TR, Perkins SM, Sandrasegaran K, et al. (2012) Evaluation of response after stereotactic body radiotherapy for hepatocellular carcinoma. Cancer 118:3191–3198CrossRefPubMed
4.
go back to reference Olsen CC, Welsh J, Kavanagh BD, et al. (2009) Microscopic and macroscopic tumor and parenchymal effects of liver stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 73:1414–1424CrossRefPubMed Olsen CC, Welsh J, Kavanagh BD, et al. (2009) Microscopic and macroscopic tumor and parenchymal effects of liver stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 73:1414–1424CrossRefPubMed
5.
go back to reference Rusthoven KE, Kavanagh BD, Cardenes H, et al. (2009) Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases. J Clin Oncol 27:1572–1578CrossRefPubMed Rusthoven KE, Kavanagh BD, Cardenes H, et al. (2009) Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases. J Clin Oncol 27:1572–1578CrossRefPubMed
6.
go back to reference Swaminath A, Massey C, Brierley JD, et al. (2015) Accumulated delivered dose response of stereotactic body radiation therapy for liver metastases. Int J Radiat Oncol Biol Phys 93:639–648CrossRefPubMed Swaminath A, Massey C, Brierley JD, et al. (2015) Accumulated delivered dose response of stereotactic body radiation therapy for liver metastases. Int J Radiat Oncol Biol Phys 93:639–648CrossRefPubMed
7.
go back to reference Sanuki N, Takeda A, Oku Y, et al. (2015) Influence of liver toxicities on prognosis after stereotactic body radiation therapy for hepatocellular carcinoma. Hepatol Res 45:540–547CrossRefPubMed Sanuki N, Takeda A, Oku Y, et al. (2015) Influence of liver toxicities on prognosis after stereotactic body radiation therapy for hepatocellular carcinoma. Hepatol Res 45:540–547CrossRefPubMed
8.
go back to reference Scorsetti M, Clerici E, Navarria P, et al. (2015) The role of stereotactic body radiation therapy (SBRT) in the treatment of oligometastatic disease in the elderly. Br J Radiol 88:20150111CrossRefPubMedPubMedCentral Scorsetti M, Clerici E, Navarria P, et al. (2015) The role of stereotactic body radiation therapy (SBRT) in the treatment of oligometastatic disease in the elderly. Br J Radiol 88:20150111CrossRefPubMedPubMedCentral
9.
go back to reference Scorsetti M, Comito T, Cozzi L, et al. (2015) The challenge of inoperable hepatocellular carcinoma (HCC): results of a single-institutional experience on stereotactic body radiation therapy (SBRT). J Cancer Res Clin Oncol 141:1301–1309CrossRefPubMed Scorsetti M, Comito T, Cozzi L, et al. (2015) The challenge of inoperable hepatocellular carcinoma (HCC): results of a single-institutional experience on stereotactic body radiation therapy (SBRT). J Cancer Res Clin Oncol 141:1301–1309CrossRefPubMed
10.
go back to reference Huertas A, Baumann AS, Saunier-Kubs F, et al. (2015) Stereotactic body radiation therapy as an ablative treatment for inoperable hepatocellular carcinoma. Radiother Oncol 115:211–216CrossRefPubMed Huertas A, Baumann AS, Saunier-Kubs F, et al. (2015) Stereotactic body radiation therapy as an ablative treatment for inoperable hepatocellular carcinoma. Radiother Oncol 115:211–216CrossRefPubMed
11.
go back to reference Bujold A, Massey CA, Kim JJ, et al. (2013) Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma. J Clin Oncol 31:1631–1639CrossRefPubMed Bujold A, Massey CA, Kim JJ, et al. (2013) Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma. J Clin Oncol 31:1631–1639CrossRefPubMed
12.
go back to reference Maturen KE, Feng MU, Wasnik AP, et al. (2013) Imaging effects of radiation therapy in the abdomen and pelvis: evaluating “innocent bystander” tissues. Radiographics 33:599–619CrossRefPubMed Maturen KE, Feng MU, Wasnik AP, et al. (2013) Imaging effects of radiation therapy in the abdomen and pelvis: evaluating “innocent bystander” tissues. Radiographics 33:599–619CrossRefPubMed
13.
go back to reference Shaffer JL, Osmundson EC, Visser BC, et al. (2015) Stereotactic body radiation therapy and central liver toxicity: a case report. Pract Radiat Oncol 5:282–285CrossRefPubMed Shaffer JL, Osmundson EC, Visser BC, et al. (2015) Stereotactic body radiation therapy and central liver toxicity: a case report. Pract Radiat Oncol 5:282–285CrossRefPubMed
14.
go back to reference Fajardo LF (1989) The unique physiology of endothelial cells and its implications in radiobiology. Front Radiat Ther Oncol 23:96–112CrossRefPubMed Fajardo LF (1989) The unique physiology of endothelial cells and its implications in radiobiology. Front Radiat Ther Oncol 23:96–112CrossRefPubMed
15.
go back to reference Fajardo LF, Colby TV (1980) Pathogenesis of veno-occlusive liver disease after radiation. Arch Pathol Lab Med 104:584–588PubMed Fajardo LF, Colby TV (1980) Pathogenesis of veno-occlusive liver disease after radiation. Arch Pathol Lab Med 104:584–588PubMed
16.
go back to reference Shulman HM, McDonald GB, Matthews D, et al. (1980) An analysis of hepatic venocclusive disease and centrilobular hepatic degeneration following bone marrow transplantation. Gastroenterology 79:1178–1191PubMed Shulman HM, McDonald GB, Matthews D, et al. (1980) An analysis of hepatic venocclusive disease and centrilobular hepatic degeneration following bone marrow transplantation. Gastroenterology 79:1178–1191PubMed
17.
go back to reference Sanuki N, Takeda A, Oku Y, et al. (2014) Stereotactic body radiotherapy for small hepatocellular carcinoma: a retrospective outcome analysis in 185 patients. Acta Oncol 53:399–404CrossRefPubMed Sanuki N, Takeda A, Oku Y, et al. (2014) Stereotactic body radiotherapy for small hepatocellular carcinoma: a retrospective outcome analysis in 185 patients. Acta Oncol 53:399–404CrossRefPubMed
18.
go back to reference Lall C, Bhargava P, Sandrasegaran K, et al. (2015) Three-dimensional conformal radiation therapy in the liver: MRI findings along a time continuum. J Comput Assist Tomogr 39:356–364PubMed Lall C, Bhargava P, Sandrasegaran K, et al. (2015) Three-dimensional conformal radiation therapy in the liver: MRI findings along a time continuum. J Comput Assist Tomogr 39:356–364PubMed
19.
go back to reference Schmid-Tannwald C, Strobl FF, Theisen D, et al. (2015) Diffusion-weighted MRI before and after robotic radiosurgery (Cyberknife®) in primary and secondary liver malignancies: a pilot study. Technol Cancer Res Treat 14:191–199PubMed Schmid-Tannwald C, Strobl FF, Theisen D, et al. (2015) Diffusion-weighted MRI before and after robotic radiosurgery (Cyberknife®) in primary and secondary liver malignancies: a pilot study. Technol Cancer Res Treat 14:191–199PubMed
20.
go back to reference Eccles CL, Haider EA, Haider MA, et al. (2009) Change in diffusion weighted MRI during liver cancer radiotherapy: preliminary observations. Acta Oncol 48:1034–1043CrossRefPubMed Eccles CL, Haider EA, Haider MA, et al. (2009) Change in diffusion weighted MRI during liver cancer radiotherapy: preliminary observations. Acta Oncol 48:1034–1043CrossRefPubMed
21.
go back to reference Stinauer MA, Diot Q, Westerly DC, et al. (2012) Fluorodeoxyglucose positron emission tomography response and normal tissue regeneration after stereotactic body radiotherapy to liver metastases. Int J Radiat Oncol Biol Phys 83:e613–e618CrossRefPubMed Stinauer MA, Diot Q, Westerly DC, et al. (2012) Fluorodeoxyglucose positron emission tomography response and normal tissue regeneration after stereotactic body radiotherapy to liver metastases. Int J Radiat Oncol Biol Phys 83:e613–e618CrossRefPubMed
22.
go back to reference Solanki AA, Weichselbaum RR, Appelbaum D, et al. (2012) The utility of FDG-PET for assessing outcomes in oligometastatic cancer patients treated with stereotactic body radiotherapy: a cohort study. Radiat Oncol 7:216CrossRefPubMedPubMedCentral Solanki AA, Weichselbaum RR, Appelbaum D, et al. (2012) The utility of FDG-PET for assessing outcomes in oligometastatic cancer patients treated with stereotactic body radiotherapy: a cohort study. Radiat Oncol 7:216CrossRefPubMedPubMedCentral
23.
go back to reference Lawrence TS, Robertson JM, Anscher MS, et al. (1995) Hepatic toxicity resulting from cancer treatment. Int J Radiat Oncol Biol Phys 31:1237–1248CrossRefPubMed Lawrence TS, Robertson JM, Anscher MS, et al. (1995) Hepatic toxicity resulting from cancer treatment. Int J Radiat Oncol Biol Phys 31:1237–1248CrossRefPubMed
24.
go back to reference Howells CC, Stinauer MA, Diot Q, et al. (2012) Normal liver tissue density dose response in patients treated with stereotactic body radiation therapy for liver metastases. Int J Radiat Oncol Biol Phys 84:e441–e446CrossRefPubMed Howells CC, Stinauer MA, Diot Q, et al. (2012) Normal liver tissue density dose response in patients treated with stereotactic body radiation therapy for liver metastases. Int J Radiat Oncol Biol Phys 84:e441–e446CrossRefPubMed
25.
go back to reference Dyk P, Weiner A, Badiyan S, et al. (2015) Effect of high-dose stereotactic body radiation therapy on liver function in the treatment of primary and metastatic liver malignancies using the Child–Pugh score classification system. Pract Radiat Oncol 5:176–182CrossRefPubMed Dyk P, Weiner A, Badiyan S, et al. (2015) Effect of high-dose stereotactic body radiation therapy on liver function in the treatment of primary and metastatic liver malignancies using the Child–Pugh score classification system. Pract Radiat Oncol 5:176–182CrossRefPubMed
26.
go back to reference Yannam GR, Han B, Setoyama K, et al. (2014) A nonhuman primate model of human radiation-induced venocclusive liver disease and hepatocyte injury. Int J Radiat Oncol Biol Phys 88:404–411CrossRefPubMed Yannam GR, Han B, Setoyama K, et al. (2014) A nonhuman primate model of human radiation-induced venocclusive liver disease and hepatocyte injury. Int J Radiat Oncol Biol Phys 88:404–411CrossRefPubMed
27.
go back to reference Osmundson EC, Wu Y, Luxton G, et al. (2015) Predictors of toxicity associated with stereotactic body radiation therapy to the central hepatobiliary tract. Int J Radiat Oncol Biol Phys 91:986–994CrossRefPubMed Osmundson EC, Wu Y, Luxton G, et al. (2015) Predictors of toxicity associated with stereotactic body radiation therapy to the central hepatobiliary tract. Int J Radiat Oncol Biol Phys 91:986–994CrossRefPubMed
28.
go back to reference Reed GB, Cox AJ (1966) The human liver after radiation injury. A form of veno-occlusive disease. Am J Pathol 48:597–611PubMedPubMedCentral Reed GB, Cox AJ (1966) The human liver after radiation injury. A form of veno-occlusive disease. Am J Pathol 48:597–611PubMedPubMedCentral
29.
go back to reference Sanuki N, Takeda A, Oku Y, et al. (2014) Threshold doses for focal liver reaction after stereotactic ablative body radiation therapy for small hepatocellular carcinoma depend on liver function: evaluation on magnetic resonance imaging with Gd-EOB-DTPA. Int J Radiat Oncol Biol Phys 88:306–311CrossRefPubMed Sanuki N, Takeda A, Oku Y, et al. (2014) Threshold doses for focal liver reaction after stereotactic ablative body radiation therapy for small hepatocellular carcinoma depend on liver function: evaluation on magnetic resonance imaging with Gd-EOB-DTPA. Int J Radiat Oncol Biol Phys 88:306–311CrossRefPubMed
30.
go back to reference Kimura T, Takahashi S, Takahashi I, et al. (2015) The time course of dynamic computed tomographic appearance of radiation injury to the cirrhotic liver following stereotactic body radiation therapy for hepatocellular carcinoma. PLoS One 10:e0125231CrossRefPubMedPubMedCentral Kimura T, Takahashi S, Takahashi I, et al. (2015) The time course of dynamic computed tomographic appearance of radiation injury to the cirrhotic liver following stereotactic body radiation therapy for hepatocellular carcinoma. PLoS One 10:e0125231CrossRefPubMedPubMedCentral
31.
go back to reference Willemart S, Nicaise N, Struyven J, van Gansbeke D (2000) Acute radiation-induced hepatic injury: evaluation by triphasic contrast enhanced helical CT. Br J Radiol 73:544–546CrossRefPubMed Willemart S, Nicaise N, Struyven J, van Gansbeke D (2000) Acute radiation-induced hepatic injury: evaluation by triphasic contrast enhanced helical CT. Br J Radiol 73:544–546CrossRefPubMed
32.
33.
go back to reference Jarraya H, Borde P, Mirabel X, et al. (2015) Lobulated enhancement evaluation in the follow-up of liver metastases treated by stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 92:292–298CrossRefPubMed Jarraya H, Borde P, Mirabel X, et al. (2015) Lobulated enhancement evaluation in the follow-up of liver metastases treated by stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 92:292–298CrossRefPubMed
34.
go back to reference Lencioni R, Llovet JM (2010) Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis 30:52–60CrossRefPubMed Lencioni R, Llovet JM (2010) Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis 30:52–60CrossRefPubMed
35.
go back to reference Chun YS, Vauthey JN, Boonsirikamchai P, et al. (2009) Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases. JAMA 302:2338–2344CrossRefPubMedPubMedCentral Chun YS, Vauthey JN, Boonsirikamchai P, et al. (2009) Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases. JAMA 302:2338–2344CrossRefPubMedPubMedCentral
36.
go back to reference Choi H, Charnsangavej C, de Castro Faria S, et al. (2004) CT evaluation of the response of gastrointestinal stromal tumors after imatinib mesylate treatment: a quantitative analysis correlated with FDG PET findings. AJR Am J Roentgenol 183:1619–1628CrossRefPubMed Choi H, Charnsangavej C, de Castro Faria S, et al. (2004) CT evaluation of the response of gastrointestinal stromal tumors after imatinib mesylate treatment: a quantitative analysis correlated with FDG PET findings. AJR Am J Roentgenol 183:1619–1628CrossRefPubMed
37.
go back to reference Jarraya H, Mirabel X, Taieb S, et al. (2013) Image-based response assessment of liver metastases following stereotactic body radiotherapy with respiratory tracking. Radiat Oncol 8:24CrossRefPubMedPubMedCentral Jarraya H, Mirabel X, Taieb S, et al. (2013) Image-based response assessment of liver metastases following stereotactic body radiotherapy with respiratory tracking. Radiat Oncol 8:24CrossRefPubMedPubMedCentral
38.
go back to reference Aitken KL, Hawkins MA (2015) Stereotactic body radiotherapy for liver metastases. Clin Oncol (R Coll Radiol) 27:307–315CrossRef Aitken KL, Hawkins MA (2015) Stereotactic body radiotherapy for liver metastases. Clin Oncol (R Coll Radiol) 27:307–315CrossRef
39.
go back to reference Aitken K, Tree A, Thomas K, et al. (2015) Initial UK experience of stereotactic body radiotherapy for extracranial oligometastases: can we change the therapeutic paradigm? Clin Oncol (R Coll Radiol) 27:411–419CrossRef Aitken K, Tree A, Thomas K, et al. (2015) Initial UK experience of stereotactic body radiotherapy for extracranial oligometastases: can we change the therapeutic paradigm? Clin Oncol (R Coll Radiol) 27:411–419CrossRef
40.
go back to reference Jarraya H, Chalayer C, Tresch E, et al. (2014) Novel technique for hepatic fiducial marker placement for stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 90:119–125CrossRefPubMed Jarraya H, Chalayer C, Tresch E, et al. (2014) Novel technique for hepatic fiducial marker placement for stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 90:119–125CrossRefPubMed
41.
go back to reference Oldrini G, Taste-George H, Renard-Oldrini S, et al. (2015) Implantation of fiducial markers in the liver for stereotactic body radiation therapy: feasibility and results. Diagn Interv Imaging 96:589–592CrossRefPubMed Oldrini G, Taste-George H, Renard-Oldrini S, et al. (2015) Implantation of fiducial markers in the liver for stereotactic body radiation therapy: feasibility and results. Diagn Interv Imaging 96:589–592CrossRefPubMed
42.
go back to reference Janoray G (2015) Mornex F [Follow-up after stereotactic body radiation therapy for liver tumours: a review of the literature and recommendations]. Cancer Radiother 19:573–581CrossRefPubMed Janoray G (2015) Mornex F [Follow-up after stereotactic body radiation therapy for liver tumours: a review of the literature and recommendations]. Cancer Radiother 19:573–581CrossRefPubMed
43.
go back to reference Herfarth KK, Hof H, Bahner ML, et al. (2003) Assessment of focal liver reaction by multiphasic CT after stereotactic single-dose radiotherapy of liver tumors. Int J Radiat Oncol Biol Phys 57:444–451CrossRefPubMed Herfarth KK, Hof H, Bahner ML, et al. (2003) Assessment of focal liver reaction by multiphasic CT after stereotactic single-dose radiotherapy of liver tumors. Int J Radiat Oncol Biol Phys 57:444–451CrossRefPubMed
44.
go back to reference Hajj C, Goodman KA (2015) Role of radiotherapy and newer techniques in the treatment of GI cancers. J Clin Oncol 33:1737–1744CrossRefPubMed Hajj C, Goodman KA (2015) Role of radiotherapy and newer techniques in the treatment of GI cancers. J Clin Oncol 33:1737–1744CrossRefPubMed
45.
go back to reference Oldrini G, Vogin G, Renard-Oldrini S, Taste-George H, Grignon B (2015) Henrot P [Post-therapeutics features of hepatocellular carcinoma treated by stereotactic body radiation therapy]. Presse Med 44:951–953CrossRefPubMed Oldrini G, Vogin G, Renard-Oldrini S, Taste-George H, Grignon B (2015) Henrot P [Post-therapeutics features of hepatocellular carcinoma treated by stereotactic body radiation therapy]. Presse Med 44:951–953CrossRefPubMed
46.
go back to reference Richter C, Seco J, Hong TS, Duda DG, Bortfeld T (2014) Radiation-induced changes in hepatocyte-specific Gd-EOB-DTPA enhanced MRI: potential mechanism. Med Hypotheses 83:477–481CrossRefPubMed Richter C, Seco J, Hong TS, Duda DG, Bortfeld T (2014) Radiation-induced changes in hepatocyte-specific Gd-EOB-DTPA enhanced MRI: potential mechanism. Med Hypotheses 83:477–481CrossRefPubMed
47.
go back to reference Kishan AU, Cao M, Wang PC, et al. (2015) Feasibility of magnetic resonance imaging-guided liver stereotactic body radiation therapy: a comparison between modulated tri-cobalt-60 teletherapy and linear accelerator-based intensity modulated radiation therapy. Pract Radiat Oncol 5:330–337CrossRefPubMed Kishan AU, Cao M, Wang PC, et al. (2015) Feasibility of magnetic resonance imaging-guided liver stereotactic body radiation therapy: a comparison between modulated tri-cobalt-60 teletherapy and linear accelerator-based intensity modulated radiation therapy. Pract Radiat Oncol 5:330–337CrossRefPubMed
Metadata
Title
Stereotactic body radiation therapy of liver tumors: post-treatment appearances and evaluation of treatment response: a pictorial review
Authors
Mustafa M. Haddad
Kenneth W. Merrell
Christopher L. Hallemeier
Geoffrey B. Johnson
Taofic Mounajjed
Kenneth R. Olivier
Jeff L. Fidler
Sudhakar K. Venkatesh
Publication date
01-10-2016
Publisher
Springer US
Published in
Abdominal Radiology / Issue 10/2016
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-016-0768-x

Other articles of this Issue 10/2016

Abdominal Radiology 10/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.